- UroToday Home
- Urologic Oncology
The Latest Bladder Cancer Research
Recent Abstracts
-
Role of Postoperative Radiation Therapy After Radical Cystectomy for Bladder Cancer: A Systematic Review and Meta-Analysis.Bladder CancerJuly 3, 2026
-
Assessing Human Epidermal Growth Factor Receptor 2 in Urothelial Carcinoma: Insights From Clinical Practice Into Scoring Criteria, Histologic Subtypes, and Genomic Characteristics Across Disease Sites.Bladder CancerJuly 3, 2026
-
A Quantitative Modification of VI-RADS for Bladder Cancer at the Ureteral Orifice: A Reader Study on MRI With Varying Experience Levels.Bladder CancerJuly 3, 2026
-
Longitudinal circulating tumour DNA identifies patients at high risk of upstaging and recurrence in non-muscle-invasive bladder cancer.Bladder CancerJuly 3, 2026
-
Extended versus Standard Lymph Node Dissection at the Time of Radical Cystectomy for Bladder Cancer.Bladder CancerJuly 2, 2026
-
Guidelines of the Oncology Committee of the French Association of Urology (CCAFU) and the Infectious Diseases Committee of the French Association of Urology (CIAFU) for Intravesical Instillation of Mitomycin C, Epirubicin, and BCG in NMIBC.Bladder CancerJuly 2, 2026
-
Management of High-Risk Non-Muscle-Invasive Bladder Cancer.Bladder CancerJuly 2, 2026
-
Impact of Social and Structural Determinants of Health on Bladder Cancer Outcomes: Focus on Non-Muscle-Invasive Disease.Bladder CancerJuly 2, 2026
-
Invasive urothelial carcinoma in association with surface low-grade papillary urothelial carcinoma: clinical and pathologic insights from a rare entity.Bladder CancerJuly 1, 2026
-
Emerging Intravesical Therapies for Non-Muscle-Invasive Bladder Cancer.Bladder CancerJuly 1, 2026
Beyond the Abstracts
-
Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma: Long-Term Outcomes from the JAVELIN Bladder 100 Trial in Patients with High Body Mass Index or Diabetes Mellitus - Beyond the AbstractBladder CancerJuly 2, 2026
-
International Survey of Thromboprophylaxis Practices During Neoadjuvant Therapy for Muscle-Invasive Bladder Cancer - Beyond the AbstractBladder CancerJuly 1, 2026
-
Targeting HER2 in Urothelial Carcinoma: Why Histologic Subtypes and Divergent Histologies Matter - Beyond the AbstractBladder CancerJune 17, 2026
-
Impact of Asymptomatic Bacteriuria on the Outcomes and Tolerability of Bacillus Calmette-Guérin Immunotherapy - Beyond the AbstractBladder CancerJune 16, 2026
-
HER2 and Urothelial Carcinoma: Current Understanding and Future Directions - Beyond the AbstractBladder CancerJune 16, 2026
-
Detection of Bladder Cancer in Patients with Microscopic Hematuria Using Oncuria-Detect: Results of a Prospective, Multicenter International Study - Beyond the AbstractBladder CancerMay 26, 2026
-
Bacillus Calmette-Guérin-exposed Non-muscle-invasive Bladder Cancer: Survival Benchmarks, Bladder-sparing Strategies, and Implications for Trial Design - Beyond the AbstractBladder CancerMay 22, 2026
-
Impact of Pelvic Lymph Node Dissection on Oncological Outcomes in Patients with Clinically Staged Non-Muscle-Invasive Bladder Cancer Undergoing Radical Cystectomy: A Systematic Review - Beyond the AbstractBladder CancerMay 22, 2026
-
Population-Based Outcomes of Chemoradiation Therapy for Muscle-Invasive Bladder Cancer in Older Adults - Beyond the AbstractBladder CancerMay 21, 2026
-
Advances and Challenges of PET Imaging in Bladder Cancer-an Update and Future Trends - Beyond the AbstractBladder CancerMay 20, 2026